CINECA IRIS Institutional Research Information System

LUNGHI, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.620
NA - Nord America 739
SA - Sud America 560
EU - Europa 305
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 33
OC - Oceania 5
Totale 3.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 671
BR - Brasile 424
HK - Hong Kong 365
SG - Singapore 346
VN - Vietnam 289
CN - Cina 211
BD - Bangladesh 147
KR - Corea 147
IT - Italia 138
AR - Argentina 58
FR - Francia 40
DE - Germania 38
ID - Indonesia 34
EC - Ecuador 33
CA - Canada 29
MX - Messico 24
GB - Regno Unito 16
CO - Colombia 15
IN - India 14
NL - Olanda 12
PK - Pakistan 11
PL - Polonia 11
PY - Paraguay 11
IQ - Iraq 10
RU - Federazione Russa 10
MA - Marocco 8
UA - Ucraina 8
ZA - Sudafrica 8
VE - Venezuela 7
FI - Finlandia 6
CL - Cile 5
SA - Arabia Saudita 5
TR - Turchia 5
AU - Australia 4
AZ - Azerbaigian 4
HN - Honduras 4
JO - Giordania 4
JP - Giappone 4
KZ - Kazakistan 4
MY - Malesia 4
RO - Romania 4
UY - Uruguay 4
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
ES - Italia 3
GT - Guatemala 3
KW - Kuwait 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
MK - Macedonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PT - Portogallo 2
SN - Senegal 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MV - Maldive 1
NC - Nuova Caledonia 1
NE - Niger 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 3.264
Salva come PNG Salva come JPEG
Città #
Hong Kong 362
San Jose 216
Seoul 147
Singapore 116
Ho Chi Minh City 110
Ashburn 90
Chicago 85
Dallas 55
Beijing 48
Hanoi 44
São Paulo 39
New York 28
Rio de Janeiro 21
Da Nang 16
Florence 16
Biên Hòa 15
Haiphong 15
Los Angeles 15
Santa Clara 15
Mexico City 13
Guayaquil 12
Milan 12
Montreal 12
Sona 12
Campinas 11
Quito 11
Rome 11
Curitiba 10
Frankfurt am Main 10
Thái Bình 10
Buffalo 9
Düsseldorf 8
Manaus 8
Munich 8
Ninh Bình 8
Amsterdam 7
Brasília 7
Bắc Ninh 6
Goiânia 6
Hillsboro 6
Hải Dương 6
Porto Alegre 6
Bologna 5
Can Tho 5
Roubaix 5
Wroclaw 5
Amman 4
Baghdad 4
Baku 4
Buenos Aires 4
Chennai 4
Denver 4
Hortolândia 4
Lauterbourg 4
London 4
Osasco 4
Ottawa 4
Québec 4
Thái Nguyên 4
Turin 4
Turku 4
Warsaw 4
Asunción 3
Atlanta 3
Bari 3
Brooklyn 3
Cairo 3
Feira de Santana 3
Formosa 3
Franca 3
Ha Long 3
Karachi 3
Kuala Lumpur 3
Lanús 3
Naples 3
Orem 3
Pelotas 3
Phoenix 3
Piracicaba 3
Portsmouth 3
Reston 3
Santo André 3
Shanghai 3
Sumaré 3
Sydney 3
São Bernardo do Campo 3
São José do Rio Preto 3
Taubaté 3
Tokyo 3
Albuquerque 2
Almaty 2
Ankara 2
As Sālimīyah 2
Bangkok 2
Belo Horizonte 2
Benito Juarez 2
Birigui 2
Bogotá 2
Boksburg 2
Bountiful 2
Totale 1.849
Salva come PNG Salva come JPEG
Nome #
Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults 75
Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies 68
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective 68
Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian 63
Alternative mechanistic paths in the Hetero-Diels-Alder reaction of α-oxothiones: A theoretical study 59
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 59
Association between stimulant and non-stimulant ADHD medications and completed suicide in adolescents and adults: A population-based nested case-control study 56
ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study 54
Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults 54
Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada 53
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment 51
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health 51
Benefits, risks and impacts on quality of life of medications used in multimorbid older adults: a Delphi study 51
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis 51
Trends in medication use during the COVID-19 pandemic in Quebec, Canada 51
Environmental sustainability — an essential component of rational use of medicines 50
Cluster B personality disorders and psychotropic medications: a focused analysis of trends and patterns across sex and age groups 49
Definition and validation of case detection algorithms using Quebec medico-administrative databases (med-echo and ramq) for depression among seniors 48
SYNHETIC IMMUNOGENIC GLYCOCONJUGATE FOR MELANOMA IMMUNOTHERAPY 47
Agreement Between Medico-Administrative Database Algorithms and Survey-Based Diagnoses for Depression and Anxiety in Older Adults 47
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada 46
Association Between Depression And Discontinuation With Antidiabetic Drugs 46
Drug Prescription Monitoring System To Estimate Incidence and Prevalence of Type 1 Diabetes 46
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response 46
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter? 46
The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey 46
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations 46
The interface of depression and diabetes: treatment considerations 45
Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone 44
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study 43
Enhancing Medication Adherence in Older Adults: A Systematic Review of Evidence-Based Strategies 43
Economic evaluations of interventions to optimize medication use in older adults with polypharmacy and multimorbidity: A systematic review 41
Is it time to consider depression as a major complication of type 2 diabetes? Evidence from a large population-based cohort study 41
Medication use in Italian nursing homes: preliminary results from the national monitoring system 40
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 40
The Association Between Depression and Medication Non-Adherence in Type 2 Diabetes: A Population-Based Cohort Study 40
Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care 40
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 39
Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study 38
Factors Associated with Antidiabetic Medication Non-Adherence in Patients with Incident Comorbid Depression 38
Scholarly publishing depends on peer reviewers 38
Prevalence of Depression in Patients with Type 2 Diabetes in Quebec: A Population-Based Cohort Study 38
Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression 38
Early career researchers’ perspectives and roles in patient-oriented research 38
Trajectories of Antidiabetic Medication Adherence in Older Adults and the Effect of Depression and Anxiety Symptoms 37
Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: A population-based retrospective cohort study 37
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 37
Comorbid Depression and All-Cause Mortality in Type 2 Diabetes: A 9-Year Cohort Study 37
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes 36
Comorbidity, trauma, and mortality in children and young adults using ADHD medications in Quebec between 2000 and 2020 36
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS 35
The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs 35
ADHD Medication Use and Psychiatric Comorbidity, Trauma and Mortality in Children and Young Adults: A Cohort Study from Quebec, Canada 35
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec’s health services register cohort 34
Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review 34
The impact of incident depression on medication adherence in patients with type 2 diabetes 33
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation 33
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward 33
Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study 33
Trends of polypharmacy among older adults with schizophrenia in Quebec, Canada between 2000 and 2017 32
Sialylexoenitols as precursors for new analogues of sialidase inhibitors 32
Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells 32
Medication use in the year before and after a diagnosis of cluster B personality disorder: Trends and patterns between 2002 and 2018 in Quebec, Canada 31
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 31
What methods are used to study the association between medication adherence trajectories, estimated with the group-based trajectory modeling (GBTM) method, and health-related outcomes?—a protocol for a systematic review 31
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 30
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency 30
Health care system costs related to potentially inappropriate medication use involving opioids in older adults in Canada 29
Estimate of incidence and prevalence of type 1 diabetes using electronic drug prescription archives 29
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 28
Risk of Psychotic Disorders Among Patients with Medical Cannabis Authorization: A Longitudinal Cohort Study 28
Utilization of Health Care Services by Patients With Cluster B Personality Disorders or Schizophrenia 28
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health 27
Use of Quebec medico-administrative databases for mental health studies: Opportunities, methodological challenges and limitations – The case of depression among diabetic subjects 27
Patient and health system factors associated with potentially inappropriate opioid use in non-cancer community-dwelling older adults 27
Stereoselective synthesis of 1,3-disaccharides through diels-alder reactions: Part 2[ ]: Convenient protecting groups for heterodienes and conformational evaluations 27
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability 27
Incidence of Depression in Patients with Diabetes in Quebec: A Population-Based Cohort Study 27
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016 26
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 26
Prevalence of Depression in Patients with Type 2 Diabetes (T2D) in Quebec 26
Structural study of liposomes loaded with a GM3 lactone analogue for the targeting of tumor epitopes 26
The prevalence of chronic antidepressant drugs prescriptions in the province of Bologna, Italy 26
Synthetic Immunogenic Glycoconjugate for melanoma immunotherapy 24
Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health 21
Long‐Term Utilization Patterns of Antidepressants in Two Italian Regions: A Naturalistic Observation of Over 2 Million Individuals Across 5 Years 6
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms 5
Healthcare professionals’ perspectives on medication adherence-supporting tools: a cross‑sectional survey in Italy 1
Totale 3.376
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.639
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.639
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025730 0 0 0 0 0 0 0 0 199 363 132 36
2025/20262.582 158 160 418 529 213 99 43 188 336 106 165 167
2026/202764 58 6 0 0 0 0 0 0 0 0 0 0
Totale 3.376